Vision-Related Quality of Life in Patients with Pituitary Adenoma

American Journal of Ophthalmology

Volumn 146, Issue 2, 2008, Pages

  Okamoto, Yoshifumi ^a   Okamoto, Fumiki ^a   Hiraoka, Takahiro ^a   Yamada, Shozo ^b   Oshika, Tetsuro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COLOR VISION; CONTROLLED STUDY; DISEASE DURATION; EYE DISEASE; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; VISUAL ACUITY;

EID: 47549083462     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.04.018     Document Type: Article

References (31)

1. Committee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (1969-1993). 10th ed. Tokyo Neurol Med Chir 40 (2000) S1-S106
2. Hollenhorst R.W., and Younge B.R. Ocular manifestations produced by adenomas of the pituitary gland: analysis of 1000 cases. In: Kohler P.O., and Ross G.T. (Eds). Diagnosis and treatment of pituitary tumors (1973), Excerpta Medica, Amsterdam 53-59
3. Ebersold M.J., Quast L.M., Laws Jr. E.R., et al. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64 (1986) 713-719
4. Anderson D., Faber P., Marcovitz S., et al. Pituitary tumors and the ophthalmologist. Ophthalmology 90 (1983) 1265-1270
5. Suzukamo Y., Oshika T., Yuzawa M., et al. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual Life Outcomes 3 (2005) 65
6. Ghazi-Nouri S.M., Tranos P.G., Rubin G.S., et al. Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery. Br J Ophthalmol 90 (2006) 559-562
7. Hyman L.G., Komaroff E., Heijl A., et al., Early Manifest Trial Group. Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology 112 (2005) 1505-1513
8. Cusick M., SanGiovanni J.P., Chew E.Y., et al. Central visual function and the NEI VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Am J Ophthalmol 139 (2005) 1042-1050
9. Berdeaux G.H., Nordmann J.P., Colin E., and Arnould B. Vision-related quality of life in patients suffering from age-related macular degeneration. Am J Ophthalmol 139 (2005) 271-279
10. Cahill M.T., Banks A.D., Stinnett S.S., and Toth C.A. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology 112 (2005) 152-158
11. Cahill M.T., Stinnett S.S., Banks A.D., et al. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology 112 (2005) 144-151
12. Tranos P.G., Ghazi-Nouri S.M., Rubin G.S., et al. Visual function and subjective perception of visual ability after macular hole surgery. Am J Ophthalmol 138 (2004) 995-1002
13. Kymes S.M., Walline J.J., Zadnik K., Gordon M.O., and Collaborative Longitudinal Evaluation of Keratoconus Study Group. Quality of life in keratoconus. Am J Ophthalmol 138 (2004) 527-535
14. Kan P., and Cusimano M. Validation of a quality-of-life questionnaire for patients with pituitary adenoma. Can J Neurol Sci 33 (2006) 80-85
15. Johnson M.D., Woodburn C.J., and Vance M.L. Quality of life in patients with a pituitary adenoma. Pituitary 6 (2003) 81-87
16. Lindsay J.R., Nansel T., Baid S., et al. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91 (2006) 447-453
17. Berglund G., Liden A., Hansson M.G., et al. Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1). Fam Canser 2 (2003) 27-33
18. Katz J., and Sommer A. Reliability indexes of automated perimetric tests. Arch Ophthalmol 106 (1988) 1252-1254
19. Ray B.S., and Patterson Jr. R.H. Surgical experience with chromophobe adenomas of the pituitary gland. J Neurosurg 34 (1971) 726-729
20. Gutierrez P., Wilson M.R., Johnson C., et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol 115 (1997) 777-784
21. Nordmann J.P., Viala M., Sullivan K., et al. Psychometric validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics 22 (2004) 197-206
22. McKean-Cowdin R., Varma R., Wu J., et al., Los Angeles Latino Eye Study Group. Severity of visual field loss and health-related quality of life. Am J Ophthalmol 143 (2007) 1013-1023
23. Varma R., Wu J., Chong K., et al., Los Angeles Latino Eye Study Group. Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology 113 (2006) 1846-1853
24. Symon L., and Jakubowski J. Transcranial management of pituitary tumours with suprasellar extension. J Neurol Neurosurg Psychiatry 42 (1979) 123-133
25. Fahlbusch R., Honegger J., and Buchfelder M. Surgical management of acromegaly. Endocrinol Metab Clin North Am 21 (1992) 669-692
26. Laws Jr. E.R., Trautmann J.C., and Hollenhorst Jr. R.W. Transsphenoidal decompression of the optic nerve and chiasm. Visual results in 62 patients. J Neurosurg 46 (1977) 717-722
27. Gnanalingham K.K., Bhattacharjee S., Pennington R., et al. The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psychiatry 76 (2005) 415-419
28. Chanson P., and Salenave S. Diagnosis and treatment of pituitary adenomas. Minerva Endocrinol 29 (2004) 241-275
29. Chanson P., and Brochier S. Non-functioning pituitary adenomas. J Endocrinol Invest 28 (2005) 93-99
30. Kars M., van der Klaauw A.A., Onstein C.S., Pereira A.M., and Romijn J.A. Quality of life is decreased in female patients treated for microprolactinoma. Eur J Endocrinol 157 (2007) 133-139
31. Heald A.H., Ghosh S., Bray S., et al. Long-term negative impact on quality of life in patients with successfully treated Cushing's disease. Clin Endocrinol 61 (2004) 458-465